Brett Hanscom, PhD
Senior Staff Scientist
Vaccine and Infectious Disease Division, Fred Hutch
Design and analytic methods for HIV prevention trials and measurement-error modeling and bias correction.
Education
University of Washington, 2014, PhD (Biostatistics)
University of Utah, 1995, MS (Statistics and Econometrics)
Middlebury College, 1992, BA (Mathematics)
Research Interests
Design and analytic methods for HIV prevention trials
Measurement-error modeling and bias correction
Current Projects
Efficacy of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for HIV Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men (HPTN 083)
Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for HIV Pre-Exposure Prophylaxis in HIV-Uninfected Women. (HPTN 084)
INTEGRA: Health Service Delivery in a Mobile Health Van to Link Persons who Inject Drugs (PWID) to Integrated Care and Prevention for Addiction, HIV, HCV. (HPTN 094)